Skip to main content
Signal8

IQVIA HOLDINGS INC. (IQV)

IQVIA Holdings Inc. is a premier global provider of sophisticated analytical insights, advanced technology solutions, and comprehensive clinical research services, catering to the life sciences industry across the Americas, Europe, Africa, and Asia-Pacific. The company's operations are structured into three key divisions: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment provides a suite of cloud-native applications, complete with implementation services, and offers real-world data solutions designed to empower life sciences and healthcare providers in generating and disseminating evidence crucial for informed decision-making and improving patient outcomes. This division also delivers strategic and operational consulting, including advanced analytics support and outsourcing of commercial processes. Furthermore, it supplies country-level performance metrics detailing pharmaceutical sales, prescribing trends, medical treatments, and promotional activities across diverse channels like retail, hospital, and mail order, with data granularity extending to regional, postal code, and individual prescriber levels. Focusing on clinical trials, the Research & Development Solutions segment offers project management, clinical monitoring, broader clinical trial support, virtual trial capabilities, and strategic planning and design services. It also manages an extensive network of laboratory services, encompassing central, genomic, bioanalytical, ADME, discovery, vaccine, and biomarker analyses. The Contract Sales & Medical Solutions segment is responsible for engaging healthcare professionals and patients, alongside providing scientific strategy and medical affairs support. IQVIA's diverse clientele includes pharmaceutical, biotechnology, medical device and diagnostic, and consumer health companies. The company maintains a strategic collaboration with HealthCore, Inc. Founded in 1982, the firm was formerly known as Quintiles IMS Holdings, Inc. before rebranding as IQVIA Holdings Inc. in November 2017. Its headquarters are located in Durham, North Carolina.

Sector: Services-Commercial Physical & Biological Research

Industry: Medical - Diagnostics & Research

IQVIA Holdings Inc. logo

IQVIA Holdings Inc.

NYSE:IQVHealthcare
-2.81%$267.33
AH$267.33+0.00%vs close
Mkt Cap$44.06B
Float149.57M
O/S164.8M
Vol
$ Vol
RVOL
Inst Own94.3%
SI2.0%
Earnings
Dilution
Pipeline2 lead-sponsored trials·0 active1 completed(148 more as collaborator)

Trials need funding. See this company's dilution risk and cash position.

Clinical Trials
Sponsor role
Status
Phase
  • Phase 1
    Terminated

    Phase I Trial of bacTRL-IL-12 in Adult Subjects With Advanced, Treatment-refractory Solid Tumours

    bacTRL-IL-12

    Cancer - Solid Tumours

    Enrollment
    5
    Start
    Aug 2019
    Primary Completion
    Dec 2020
    Completion
    Dec 2020
    NCT04025307
  • Observational
    Completed

    COVID-19 Active Research Experience (CARE)

    -

    COVID-19

    Enrollment
    35,278
    Start
    Apr 2020
    Primary Completion
    Feb 2023
    Completion
    Feb 2023
    NCT04368065